Asbestos Litigation Surges as Talc Claims Explode, New Report Reveals

WASHINGTON, D.C. – April 29, 2026 – The landscape of asbestos litigation is experiencing a significant upheaval, with total filings reaching levels not seen since 2017, according to a new report from KCIC. The Washington, D.C.-based consultancy’s 2025 Asbestos Litigation Year in Review, released today, paints a picture of a legal battleground being reshaped by a dramatic surge in talc-related claims and shifting jurisdictional dynamics.

In a field long characterized by its complexity and lack of a central national registry, the annual KCIC report provides one of the most comprehensive data-driven analyses available. This year’s findings indicate that after a period of relative stability, the overall trend in asbestos filings has turned upward, driven primarily by claims for mesothelioma and lung cancer, which account for approximately 50% and 40% of all cases, respectively.

"Asbestos litigation continues to shift, particularly in how exposures are alleged and cases are filed," said Megan Burns, Managing Director at KCIC. "This report gives stakeholders a clear, data-driven view of those changes and what they may signal going forward."

Shifting Battlegrounds and Legislative Tug-of-War

The report highlights not just how many cases are being filed, but where. Certain jurisdictions are solidifying their status as litigation hotspots. Madison County and St. Clair County in Illinois, for instance, continue to be epicenters of asbestos litigation. St. Clair County saw a substantial rise in lung cancer filings, while both counties recorded notable increases in mesothelioma cases in 2024.

This concentration is further amplified by legislative changes. In August 2025, Illinois enacted a new law expanding the ability of its courts to hear asbestos cases, potentially attracting even more filings to the state. This plaintiff-friendly move stands in stark contrast to efforts in other states. Lawmakers in Missouri, Georgia, and Arkansas have recently introduced or passed legislation aimed at limiting personal injury claims by shortening statutes of limitations or changing how medical damages are calculated. This creates a fractured legal map where the outcome of a case can be heavily influenced by its geography.

Historically prominent jurisdictions like West Virginia are also undergoing transformation. Facing a backlog of thousands of cases burdened by the practice of "over-naming"—where plaintiffs name dozens or even hundreds of defendants—the state's judiciary is pushing for reforms to move from a volume-driven docket to one focused more on evidence.

The Talc Explosion: A New Frontier

Perhaps the most significant trend identified in the KCIC report is the explosive growth of talc-related claims. The report's expanded analysis reveals that allegations of asbestos exposure from talcum powder now feature in approximately 40% of all mesothelioma filings. This represents a staggering increase from just 16% in 2019, fundamentally altering the character of modern asbestos litigation.

This statistical surge is mirrored by a series of massive jury verdicts against corporate defendants, most notably Johnson & Johnson. In recent months, juries have delivered staggering awards, including a $1.5 billion verdict in Baltimore and a $966 million verdict in California for plaintiffs who developed mesothelioma after lifelong use of talc-based powders. These verdicts follow years of mounting scientific evidence and internal corporate documents suggesting that some talc products were contaminated with asbestos.

Adding to the corporate pressure, Johnson & Johnson has been repeatedly blocked by federal courts from using a controversial bankruptcy strategy known as the "Texas Two-Step" to resolve its talc liabilities. The most recent dismissal of an $8 billion settlement proposal in March 2025 forces the company back into the traditional tort system, where it faces tens of thousands of individual lawsuits and the prospect of more multi-million-dollar verdicts. The judicial rejection of these bankruptcy maneuvers signals a broader reluctance to allow corporations to sidestep jury trials in mass tort cases.

The Ripple Effect on Corporate Risk and Industry

The dual trends of rising filings and blockbuster talc verdicts are sending shockwaves through corporate boardrooms and the insurance industry. The financial exposure is not just growing; it's becoming more expensive on a per-case basis. Analysis from other industry experts at NERA Economic Consulting shows that the average cost per resolved asbestos claim rose 12% in 2024 alone and has increased by a cumulative 191% since 2017, indicating that defendants are paying significantly more to settle claims.

The intense legal and public scrutiny has forced a reckoning within the cosmetic industry. Many manufacturers are proactively reformulating products to be talc-free, opting for alternatives like cornstarch, and increasing transparency about their ingredients. This shift reflects a direct response to both litigation risk and growing consumer demand for product safety, a trend that is likely to accelerate as regulatory bodies in the U.S. and abroad consider stricter oversight of cosmetic ingredients.

For insurers, the evolving landscape creates profound uncertainty. The escalating cost per claim and the expansion of liability to new types of defendants in the talc cases require a constant re-evaluation of risk models and financial reserves. The unpredictable nature of jury awards and the failure of large-scale settlement attempts make it increasingly difficult to forecast long-term liability.

Navigating the Maze with Data

In this complex and high-stakes environment, data has become an indispensable tool. The KCIC report underscores a curious paradox: while diagnoses for diseases like mesothelioma are reportedly decreasing according to federal health data, the "propensity to sue" is on the rise. This suggests that litigation trends are becoming decoupled from epidemiological trends, driven instead by legal strategy and evolving theories of liability.

The granular data on filing types, defendant naming patterns, and jurisdictional nuances provided by the report offers defendants, insurers, and legal experts a crucial compass for navigating the maze. As the litigation evolves, so do the defense strategies. Legal experts note the emergence of novel arguments, such as citing a plaintiff's genetic predisposition to cancer as a defense to challenge the long-held assumption that asbestos exposure was the sole cause of their illness. This new front in the scientific and legal debate ensures that even after decades, the asbestos litigation saga is far from over; it is simply entering a new, more complex chapter.